Published in Invest Ophthalmol Vis Sci on May 02, 2014
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis. J Natl Cancer Inst (2014) 1.02
Proangiogenic Function of T Cells in Corneal Transplantation. Transplantation (2016) 0.82
T-helper-associated cytokines expression by peripheral blood mononuclear cells in patients with polypoidal choroidal vasculopathy and age-related macular degeneration. BMC Ophthalmol (2016) 0.76
Effect of Endometrial Injury on Secretion of Endometrial Cytokines and IVF Outcomes in Women with Unexplained Subfertility. Mediators Inflamm (2015) 0.75
Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases. Biomed Res Int (2014) 0.75
Animal models of ocular angiogenesis: from development to pathologies. FASEB J (2017) 0.75
Cellular responses to interferon-gamma. Annu Rev Immunol (1997) 13.23
Functions of natural killer cells. Nat Immunol (2008) 9.88
Human natural killer cells. Blood (2008) 7.37
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 6.54
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst (1995) 3.53
Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.17
Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73
Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A (2002) 2.32
Ranibizumab: Phase III clinical trial results. Ophthalmol Clin North Am (2006) 2.25
Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol (2007) 1.94
Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol (1998) 1.66
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells. Cancer Res (2003) 1.63
Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension. Circulation (2012) 1.59
Natural killer cell biology: an update and future directions. J Allergy Clin Immunol (2013) 1.56
Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J (2002) 1.27
Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol (2009) 1.23
Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci (2007) 1.17
Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood (1999) 1.15
Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J Immunol (2011) 1.14
The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res (2000) 1.11
A novel pro-lymphangiogenic function for Th17/IL-17. Blood (2011) 1.08
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia (2013) 1.02
Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol (2011) 1.00
Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling. Nutr Cancer (2005) 0.93
Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6. Invest Ophthalmol Vis Sci (2004) 0.84
Age-related macular degeneration is associated with the HLA-Cw*0701 Genotype and the natural killer cell receptor AA haplotype. Invest Ophthalmol Vis Sci (2008) 0.84
Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and α4β7 integrin expression by NK cells. J Immunol (2010) 0.82
Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization. Biochem Biophys Res Commun (2008) 0.79
Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol (2007) 3.96
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol (2009) 2.65
Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol (2012) 2.23
Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol (2009) 2.19
Short-term topical bevacizumab in the treatment of stable corneal neovascularization. Am J Ophthalmol (2012) 2.14
Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology (2012) 2.07
Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol (2009) 2.06
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A (2006) 1.81
Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology (2010) 1.80
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol (2009) 1.60
Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci (2009) 1.42
In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Transplantation (2016) 1.42
Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci (2011) 1.37
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res (2012) 1.32
A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain. Invest Ophthalmol Vis Sci (2011) 1.27
Validation and repeatability of a short questionnaire for dry eye syndrome. Am J Ophthalmol (2006) 1.24
Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol (2009) 1.23
Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci (2009) 1.21
Unilateral herpes zoster ophthalmicus results in bilateral corneal nerve alteration: an in vivo confocal microscopy study. Ophthalmology (2012) 1.20
Efficacy of topical blockade of interleukin-1 in experimental dry eye disease. Am J Ophthalmol (2012) 1.18
Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci (2009) 1.18
Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol (2010) 1.18
Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. Arch Ophthalmol (2009) 1.16
Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease. Arch Ophthalmol (2008) 1.13
Development and validation of a short global dry eye symptom index. Ocul Surf (2007) 1.12
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med (2011) 1.10
Characterization of Langerin-expressing dendritic cell subsets in the normal cornea. Invest Ophthalmol Vis Sci (2011) 1.08
A novel pro-lymphangiogenic function for Th17/IL-17. Blood (2011) 1.08
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
Alkali burn to the eye: protection using TNF-α inhibition. Cornea (2014) 1.07
Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci (2011) 1.07
Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci (2008) 1.05
Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol (2006) 1.04
Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling. Invest Ophthalmol Vis Sci (2008) 1.04
The structure and function of the limbal stem cell and the disease states associated with limbal stem cell deficiency. Int Ophthalmol Clin (2009) 1.03
Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J Leukoc Biol (2012) 1.02
Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch Ophthalmol (2011) 1.01
Ocular graft-versus-host disease: a review. Surv Ophthalmol (2013) 1.00
Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol (2011) 1.00
Dependence of corneal stem/progenitor cells on ocular surface innervation. Invest Ophthalmol Vis Sci (2012) 1.00
International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep (2013) 0.99
High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen. Cornea (2009) 0.98
VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. Transplantation (2015) 0.96
Cellular changes of the corneal epithelium and stroma in herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology (2012) 0.95
Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation (2009) 0.95
Effect of topical azithromycin on corneal innate immune responses. Invest Ophthalmol Vis Sci (2011) 0.94
Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.94
Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis. Invest Ophthalmol Vis Sci (2012) 0.93
The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci (2013) 0.93
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol (2011) 0.93
Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway. Blood (2011) 0.93
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J Immunol (2010) 0.92
Corneal lymphangiogenesis: implications in immunity. Semin Ophthalmol (2009) 0.92
The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee. Invest Ophthalmol Vis Sci (2011) 0.92
Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci (2013) 0.92
The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens. Mol Vis (2008) 0.91
Kinetics and function of mesenchymal stem cells in corneal injury. Invest Ophthalmol Vis Sci (2012) 0.91
Comparative analysis of human-derived feeder layers with 3T3 fibroblasts for the ex vivo expansion of human limbal and oral epithelium. Stem Cell Rev (2012) 0.91
Blocking the path of lymphatic vessels. Nat Med (2009) 0.90
Corneal nerve alterations in dry eye-associated ocular surface disease. Int Ophthalmol Clin (2009) 0.90
Gamma-irradiation reduces the allogenicity of donor corneas. Invest Ophthalmol Vis Sci (2012) 0.90
The culture and transplantation of human limbal stem cells. J Cell Physiol (2010) 0.90
CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue. J Immunol (2013) 0.90
Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea (2011) 0.90
Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf (2005) 0.90
Topical ranibizumab as a treatment of corneal neovascularization. Cornea (2013) 0.89
Inflammatory corneal neovascularization: etiopathogenesis. Semin Ophthalmol (2011) 0.89
Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation. Invest Ophthalmol Vis Sci (2009) 0.88
Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci (2013) 0.88
A novel function for programmed death ligand-1 regulation of angiogenesis. Am J Pathol (2011) 0.87
Differentiation potential of limbal fibroblasts and bone marrow mesenchymal stem cells to corneal epithelial cells. Stem Cells (2014) 0.87